Axinn Secures Antitrust Clearance for McKesson’s Transaction with Change Healthcare to Form $3.4 Billion New Health Care Information Technology Company
December 21, 2016
Axinn was antitrust counsel to McKesson Corporation, a leading global health care services and information technology company, in a transaction with Change Healthcare Holdings, Inc., a leading provider of software and analytics, network solutions and technology-enabled services, to create a new health care information technology company. The deal will combine substantially all of Change Healthcare’s business and the majority of McKesson Technology Solutions into a new company with $3.4 billion in pro forma combined total annual revenues for the fiscal year ended March 31, 2016.
The Axinn team secured unconditional antitrust clearance for the transaction after successfully navigating a more than six-month investigation by the Department of Justice, including a Second Request.
The Axinn team was led by Daniel Bitton, Jeny Maier, Russell Steinthal and Mike Keeley, assisted by Morris Bloom.
https://www.sec.gov/Archives/edgar/data/927653/000119312516701938/d220900d8k.htm
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ABA White Collar Crime Institute 2026
Speaking Engagement
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
CLA Antitrust and Consumer Protection Section In-House Counsel Summit
Speaking Engagement
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
DOJ’s First Antitrust Whistleblower Payout Signals a New Enforcement Playbook
Axinn Viewpoints
Antitrust
First Whistleblower Reward Sparks Race to Report, Lawyers Say
Media Mentions
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Healthcare Antitrust Year-In-Review Webinar
Webinar
Antitrust
Antitrust Becoming a Go-To Play in Junior College Athletes' Playbooks
Axinn Viewpoints
Antitrust